Prescription For Profit

Prescription For Profit

Share this article


  • Pure Health, the UAE’s largest healthcare group, experienced a robust debut on the Abu Dhabi Securities Exchange after a successful initial public offering (IPO) that raised Dh3.62 billion ($986 million). The company's shares opened at Dh5.50, surging by 77% to Dh5.77 in early trading before settling at Dh5.74 at the close. The IPO, priced at Dh3.26 per share, involved 1.11 billion ordinary shares, constituting 10% of the total issued share capital, with the founders retaining a 90% stake. The retail tranche was oversubscribed 483 times, and the institutional offering attracted Dh186 billion, reflecting a 54-times oversubscription level.
  • Pure Health's IPO aligns with a wider trend of increased listing activities in the Arabian Gulf, driven by government incentives, foreign investor interest, and diversification efforts. The company's debut on the ADX coincided with the appointment of Shaista Asif, co-founder and group COO, as the new group CEO. Farhan Malik, co-founder, and managing director will now focus on leading global business development efforts. Pure Health, formed in January 2022 through a merger with ADQ's healthcare subsidiaries, boasts a comprehensive network with over 25 hospitals, 100 clinics, diagnostic centers, health insurance solutions, pharmacies, and health technology platforms.

Why it matters

Pure Health's IPO comes in the middle of a listings boom in the Arabian Gulf. IPO activity in the wider Mena region continued to gather momentum in the second quarter of 2023, as the volume of IPOs on regional bourses surged 44 per cent annually amid robust economic growth, data from global consultancy EY showed. 

akbaraka

Get Smarter
About Investing

Join 35,000+ subscribers and get our 5 min daily newsletter on daily local and international financial news.
akhbaraka
Get Smarter<br/> About Investing

Similar News